Holly Zirnheld
Nurse Practitioner · Louisville, KYNPI 1669058483
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 47.1% of the total. Reporting peaked in 2024 at $4,901 and has fallen 99.0% since, to $50 in 2025. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$2K
- Actelion Pharmaceuticals US, Inc.$420
- Cvrx, Inc.$408
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$404
- Boehringer Ingelheim$380
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$1,76519%
- Travel & lodging$2,12822%
- Food & beverage$5,57459%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 30 | $4,463 |
| Abbott | 19 | $1,746 |
| Actelion Pharmaceuticals US, Inc. | 20 | $420 |
| Cvrx, Inc. | 15 | $408 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $404 |
| Boehringer Ingelheim | 18 | $380 |
| Novartis | 14 | $255 |
| Merck | 12 | $198 |
| E.r. Squibb & Sons, L.L.C. | 12 | $193 |
| Abiomed | 4 | $180 |
| Alnylam Pharmaceuticals Inc. | 8 | $164 |
| Pfizer | 8 | $156 |
| Scpharmaceuticals Inc. | 6 | $116 |
| AstraZeneca | 6 | $86 |
| Bayer | 4 | $73 |
| Lexicon Pharmaceuticals, Inc. | 3 | $63 |
| Novo Nordisk | 3 | $54 |
| Impulse Dynamics (USA) Inc. | 2 | $51 |
| Daxor Corporation | 1 | $25 |
| Boston Scientific | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,467 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 149 | $181,734 |
| EliquisApixaban | 129 | $132,146 |
| FarxigaDapagliflozin Propanediol | 84 | $58,147 |
| JardianceEmpagliflozin | 29 | $40,361 |
| RybelsusSemaglutide | 11 | $10,480 |
| Sildenafil Citrate | 21 | $8,719 |
| Bumetanide | 72 | $3,179 |
| Potassium Chloride | 90 | $2,407 |
| Isosorbide Dinitrate | 11 | $1,637 |
| Metoprolol Succinate | 95 | $1,146 |
| Amiodarone Hcl | 78 | $941 |
| Pantoprazole Sodium | 74 | $652 |
| Digoxin | 21 | $584 |
| Torsemide | 17 | $560 |
| Mexiletine Hcl | 16 | $559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $255 | $181,734149 claims |
| PfizerEliquis | $156 | $132,146129 claims |
| AstraZenecaFarxiga | $86 | $58,14784 claims |
| Boehringer IngelheimJardiance | $380 | $40,36129 claims |
| Novo NordiskRybelsus | $54 | $10,48011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Louisville
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Rebecca BraunerLouisville$40K
- Thomas FreelsLouisville$20K
- Christy BakerLouisville$18K
- Blair WagnerLouisville$15K
- Kathryn WestLouisville$13K
- Kimberly RobinsonLouisville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.